Rijksinstituut voor Volksgezondheid en Milieu
Association between adverse events after COVID-19 vaccination and anti-SARS-CoV-2 antibody concentrations, the Netherlands, May 2021 to November 2022: a population-based prospective cohort study | RIVM
Bron:
rivm.nl